Abrocitinib Impurities

per page

Abrocitinib Related Compound

Abrocitinib is a kinase inhibitor that is used to treat individuals with moderate-to-severe atopic dermatitis.




What is the generic name for abrocitinib?

The US Food and Drug Administration has approved Pfizer’s CIBINQO® (abrocitinib) for adults with moderate-to-severe atopic dermatitis.

Which abrocitinib formulations are available on the market?

This medication available in the following dose forms: tablet.

Is abrocitinib available on the NHS?

The NHS provides abrocitinib (Cibinqo) and upadacitinib (Rinvoq). They are potential therapies for severe atopic dermatitis (eczema) in adults and adolescents aged 12 and above if at least one systemic immunosuppressant has not performed well enough if systemic immunosuppressants are ineffective.